Neuropathy usually begins with damage to the smallest, most vulnerable nerve fibers in the body, long before numbness or weakness becomes obvious. The earliest injury often occurs at the tips of the longest nerves, which is why people tend to notice something wrong in their toes or the soles of their feet first. The underlying trigger varies widely, from chronically elevated blood sugar to alcohol toxicity to an immune system attacking its own nerve tissue, but the pattern of onset shares a common thread: the body’s thinnest, least-protected nerve fibers lose function quietly, producing subtle sensations that are easy to dismiss.
Why the Feet Come First
The most common form of neuropathy is called distal sensory peripheral neuropathy, and its hallmark is a “length-dependent” pattern of damage. The longest nerve fibers in your body run from the lower spinal cord all the way down to your toes. Because these fibers are the longest, they have the most territory to maintain and are the first to show signs of stress. Early symptoms typically include tingling, prickling, or mild discomfort beginning in the toes and feet, then gradually creeping upward in a symmetric pattern often described as a “stocking-glove” distribution, eventually reaching the legs, hands, and arms.1PubMed Central. Distal Sensory Peripheral Neuropathy: An Undervalued Determinant of Wellbeing This is not random. The nerve cell body sits near the spinal cord and has to supply nutrients and repair signals along the entire length of its fiber. The farther from the cell body, the harder that job becomes, so the distant tips fail first.
The fibers that go earliest are the small ones: thin, unmyelinated or lightly myelinated nerves responsible for sensing pain, temperature, and light touch. Symptoms from these small fibers include burning sensations, abnormal sensitivity to touch, coldness, and sharp or shooting pains, often following that same length-dependent pattern.2PubMed. Small fiber neuropathy: Getting bigger! Larger nerve fibers, which handle vibration sense, proprioception, and motor control, tend to hold up longer. That is why people can have weeks or months of burning feet before they notice any actual numbness or muscle weakness.
The Dominant Cause Is Metabolic
Diabetes is the single most common cause of peripheral neuropathy worldwide, and the mechanism is well studied. Chronically high blood sugar overloads normal metabolic pathways in nerve cells. Excess glucose floods the electron transport chain inside mitochondria, generating reactive oxygen species that damage the nerve from the inside out.3PubMed Central. Mechanisms of disease: the oxidative stress theory of diabetic neuropathy This oxidative stress then triggers a cascade of secondary problems, including the buildup of advanced glycation end products, activation of inflammatory signaling pathways, and disruption of the sorbitol and protein kinase C pathways.4PubMed Central. Diabetic neuropathy and oxidative stress: therapeutic perspectives
On top of that metabolic assault, the blood supply to the nerves themselves gets compromised. The tiny blood vessels that feed peripheral nerves, called the vasa nervorum, develop structural defects in diabetes. Loss of the normal nerve-controlled regulation of blood flow in these vessels leads to reduced oxygen delivery inside the nerve bundles, creating patches of ischemia. That oxygen deprivation causes focal fiber loss, particularly in proximal nerve segments, compounding the distal damage that was already underway.5Journal of Neuropathology & Experimental Neurology. Innervation of the Vasa Nervorum: Changes in Human Diabetics The combination of metabolic toxicity and vascular strangulation is what makes diabetic neuropathy so difficult to reverse once it is established. The condition is often diagnosed late, after irreversible nerve damage has already occurred.6Nature Reviews Endocrinology. Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy
Prediabetes and Metabolic Syndrome as an Underrecognized Trigger
One of the more important findings in neuropathy research over the past two decades is that you do not need a diabetes diagnosis to develop nerve damage from metabolic problems. Impaired glucose tolerance, commonly called prediabetes, is associated with neuropathy, and individual components of metabolic syndrome, including high blood pressure, abnormal lipid levels, and obesity, each appear to influence risk independently.7Journal of the Neurological Sciences. Idiopathic neuropathy, prediabetes and the metabolic syndrome
The mechanism involves a self-reinforcing loop. When skeletal muscles become resistant to insulin, fat cells pick up the slack in absorbing glucose, which stimulates the release of free fatty acids and triglycerides. Oxidized lipoproteins bind to receptors on cells and trigger further oxidative stress and inflammation. The result is microvascular injury and direct peripheral nerve damage, driven by the same kinds of oxidative and inflammatory processes seen in full-blown diabetes but starting at an earlier metabolic stage.8PubMed Central. Peripheral neuropathy in prediabetes and the metabolic syndrome This matters because many people labeled as having “idiopathic” neuropathy, meaning no identified cause, actually have undiagnosed metabolic syndrome or glucose intolerance that never showed up on a standard fasting blood sugar test.
Alcohol and Nutritional Deficiency
Heavy alcohol use is another major cause, and the relationship is more nuanced than simply “drinking damages nerves.” Research has shown that alcoholic neuropathy is actually a distinct condition from neuropathy caused purely by thiamine (vitamin B1) deficiency, even though the two frequently overlap. Alcohol and its breakdown products appear to have a direct toxic effect on nerve fibers, separate from the nutritional deficiencies that heavy drinkers tend to develop.9PubMed. Alcoholic neuropathy is clinicopathologically distinct from thiamine-deficiency neuropathy In practice, though, most people with alcohol-related neuropathy have both problems occurring simultaneously: direct toxicity from ethanol and a thiamine deficit from poor nutrition, each worsening the other.10PubMed Central. Alcoholic neuropathy: possible mechanisms and future treatment possibilities
Thiamine deficiency can also develop independently of alcohol use, especially in people with severe dietary restrictions, malabsorption conditions, or after bariatric surgery. Other nutritional causes of neuropathy include deficiency of vitamins B6, B12, and E, as well as copper. In these cases, the nerve damage starts the same way, affecting the smallest distal fibers first, but it may be partially or fully reversible if the deficiency is corrected early enough.
Chemotherapy and Drug-Induced Nerve Damage
Certain chemotherapy drugs are well known for causing peripheral neuropathy, and the mechanism is particularly brutal because it targets the nerve cell’s internal machinery. Drugs like cisplatin bind directly to mitochondrial DNA inside the sensory nerve cells of the dorsal root ganglia. Unlike nuclear DNA, mitochondrial DNA lacks effective repair mechanisms, so the damage accumulates and eventually triggers cell death.11Frontiers in Molecular Neuroscience. Current understanding of the molecular mechanisms of chemotherapy-induced peripheral neuropathy Other chemotherapy agents disrupt the nerve’s internal transport system, impairing the movement of proteins and organelles along the length of the axon. Since the longest sensory fibers depend most heavily on this transport, the result is, once again, a distal-to-proximal pattern of damage.
Chemotherapy-induced neuropathy can begin during treatment or show up weeks after the last dose, a phenomenon sometimes called “coasting.” The severity ranges from mild tingling to disabling pain and loss of hand function, and it is one of the most common reasons patients have to reduce or stop cancer treatment early. Beyond chemotherapy, other medications linked to neuropathy include certain antibiotics, antiviral drugs, and some heart medications, though the risk is considerably lower.
When the Immune System Attacks the Nerve
Autoimmune and inflammatory neuropathies work differently from metabolic or toxic types. Rather than slow, cumulative damage, the immune system mounts an active attack on components of the peripheral nerve. In conditions like chronic inflammatory demyelinating polyneuropathy (CIDP), immune cells target the myelin sheath that insulates nerve fibers, or attack specific proteins at the nodes of Ranvier where nerve signals jump between segments. Research has shown that antibodies from roughly a third of CIDP patients specifically target these nodal and paranodal regions.12PubMed Central. Pathology explains various mechanisms of auto-immune inflammatory peripheral neuropathies
Guillain-Barré syndrome is the acute counterpart, where immune-mediated damage to either myelin or the axon itself develops over days to weeks, often following an infection. The distinction between demyelinating and axonal forms matters because demyelinating neuropathies produce a different pattern on nerve conduction studies: widespread slowing of signal speed along the entire nerve, as opposed to the preferential slowing at distal sites seen with axonal damage.13PubMed. Differentiation between axonal and demyelinating neuropathies: identical segments recorded from proximal and distal muscles Recognizing autoimmune neuropathy early matters because, unlike most metabolic forms, it often responds to immunotherapy.
Infections That Target Nerves
Several infections can trigger neuropathy either by directly invading nerve tissue or by provoking an immune response that damages nerves as collateral. Varicella zoster virus, the cause of chickenpox, is one of the most common culprits. After the initial infection, the virus goes dormant in sensory nerve ganglia along the spine and cranial nerves. Decades later, when immune surveillance weakens, the virus can reactivate, producing shingles: a painful rash confined to the skin area served by the affected nerves.14PubMed Central. Review: The neurobiology of varicella zoster virus infection The reactivation causes inflammation and nerve cell death, and in some people the pain persists long after the rash heals, a condition called postherpetic neuralgia.15Nature Reviews Disease Primers. Varicella zoster virus infection
HIV is another infection strongly associated with neuropathy. Distal sensory polyneuropathy is one of the most common neurological complications among people with HIV, and it can result from the virus itself, the immune response it provokes, or as a side effect of antiretroviral medications. Other infections linked to peripheral neuropathy include Lyme disease, hepatitis C, and leprosy, each with its own pattern of nerve involvement.
Inherited Neuropathies
Not all neuropathy is acquired. Charcot-Marie-Tooth disease is a group of inherited conditions that cause progressive nerve damage, usually beginning in the feet and lower legs. These disorders result from mutations in genes responsible for the structure or function of peripheral nerves, and they can be inherited in dominant or recessive patterns. Mutations in genes like PMP22, MPZ, and EGR2 are among the most common causes of early-onset hereditary neuropathies, sometimes producing symptoms within the first year of life.16Brain. Genetic spectrum of hereditary neuropathies with onset in the first year of life Other mutations, such as those in the GDAP1 gene, produce severe motor and sensory neuropathy with additional features like vocal cord paralysis.17PubMed. Clinical, electrophysiological and morphological findings of Charcot-Marie-Tooth neuropathy with vocal cord palsy and mutations in the GDAP1 gene
Inherited neuropathies tend to progress slowly over years, and because symptoms begin so gradually, people sometimes go a long time before being evaluated. A family history of foot deformities, high arches, or difficulty walking can be a clue that a neuropathy has a genetic basis rather than an acquired one.
Mechanical Compression
Sometimes neuropathy starts not from a systemic disease but from physical pressure on a nerve. Carpal tunnel syndrome is the most familiar example. The initial damage comes from obstruction of venous blood flow within the nerve bundles as pressure builds inside the confined space of the carpal tunnel. That obstruction leads to swelling inside the nerve fibers, which raises the internal pressure further and progressively impairs blood supply, eventually destroying nerve fibers through a combination of oxygen deprivation and direct compression.18PubMed. The nerve lesion in the carpal tunnel syndrome This is why early carpal tunnel syndrome produces intermittent tingling and numbness in the fingers before progressing to permanent sensory loss and muscle wasting in the hand if left untreated.
Other entrapment neuropathies follow the same basic principle: a nerve gets squeezed at an anatomical bottleneck. The ulnar nerve at the elbow, the peroneal nerve at the fibular head near the knee, and the lateral femoral cutaneous nerve at the groin are all common sites. These focal neuropathies differ from systemic types in that the damage is localized to one nerve, making them more amenable to surgical decompression if caught early.
Autonomic Symptoms That Get Overlooked
When people think of neuropathy, they think of tingling and pain. But peripheral nerves also control involuntary functions like heart rate, blood pressure regulation, digestion, bladder function, and sweating. Damage to these autonomic nerve fibers can produce symptoms that seem completely unrelated to a “nerve problem,” which is why autonomic neuropathy is frequently missed. In diabetes, autonomic neuropathy can involve the cardiovascular system, the gastrointestinal tract, the urinary system, and the sweat glands.19PubMed. Detecting and treating the protean manifestations of diabetic autonomic neuropathy
Sudomotor dysfunction, meaning abnormal sweating patterns in the feet, can serve as an early indicator of autonomic damage, sometimes appearing before other neuropathy symptoms become obvious.20PubMed Central. Sudomotor Dysfunction of Feet Is Associated with Cardiac Autonomic Neuropathy in Patients with Type 2 Diabetes: A Cross-Sectional Study If your feet have become unusually dry and cracked, or you have noticed that one foot sweats differently from the other, that could reflect early small fiber autonomic damage rather than just dry skin. Other autonomic red flags include lightheadedness when standing up, unexplained nausea or bloating, difficulty emptying your bladder completely, and erectile dysfunction.
How Early Nerve Damage Gets Detected
One of the frustrating aspects of early neuropathy is that standard nerve conduction studies, the electrical tests most neurologists order first, mainly measure the function of large myelinated fibers. Small fiber damage can be well underway with completely normal nerve conduction results. This is a major reason small fiber neuropathy was historically underdiagnosed.
Skin biopsy has become an important tool for closing that gap. A small punch biopsy, usually taken from the lower leg, allows direct counting of the tiny nerve endings that penetrate the outer layer of skin. Morphological changes, degeneration, and abnormal regeneration of these cutaneous nerves appear very early in the course of neuropathy, sometimes before a person has noticeable symptoms.21Nature Clinical Practice Neurology. Skin biopsy as a diagnostic tool in peripheral neuropathy
An even less invasive option is corneal confocal microscopy, a quick imaging technique borrowed from ophthalmology. The cornea of the eye has one of the densest networks of small nerve fibers in the body, and those fibers degenerate in the same conditions that damage peripheral nerves elsewhere. Research has shown that this technique has comparable ability to detect neuropathy as skin biopsy for conditions like diabetic neuropathy and fibromyalgia, and it can identify nerve fiber loss before clinical symptoms appear.22PubMed Central. Corneal Confocal Microscopy to Image Small Nerve Fiber Degeneration: Ophthalmology Meets Neurology In studies comparing patients with painful versus painless diabetic neuropathy, those with pain had significantly lower corneal nerve fiber density and length, and these measures correlated with the severity of neuropathic symptoms and reduced quality of life.23Scientific Reports. Corneal confocal microscopy detects small nerve fibre damage in patients with painful diabetic neuropathy
Blood Biomarkers on the Horizon
Researchers have been searching for a simple blood test that could flag nerve damage before symptoms become severe. The most promising candidate so far is neurofilament light chain, a structural protein released into the bloodstream when nerve fibers are injured or dying. In people with diabetes, higher levels of this protein are associated with the presence and severity of neuropathy, including slower nerve conduction velocities and reduced sensory nerve function, even after accounting for other factors like age and kidney function.24PubMed Central. Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy
The same biomarker shows promise in chemotherapy-induced neuropathy, where levels rise progressively during treatment in a pattern that tracks closely with patient-reported symptoms and physician assessments. Because neurofilament light chain is highly specific to neuronal damage, it offers a potential advantage over other markers that reflect more general tissue injury.25Scientific Reports. Serum neurofilament light chain levels as a biomarker of neuroaxonal injury and severity of oxaliplatin-induced peripheral neuropathy A routine blood draw that could catch nerve damage at its earliest stages would be a meaningful clinical advance, though this test has not yet entered standard clinical practice for neuropathy screening.
Experimental Paths Toward Reversing Early Damage
Most current treatments for neuropathy focus on managing symptoms, primarily pain, rather than repairing nerves. That is starting to shift in the research space. In animal models of diabetic neuropathy, several approaches have shown the ability to prevent or even reverse nerve abnormalities, including drugs that activate growth signals in sensory neurons and interventions that boost heat shock protein expression, a cellular stress-response pathway that protects neurons.26PubMed Central. Diabetic neuropathy and the sensory neuron: New aspects of pathogenesis and their treatment implications Early-stage research has also explored the gut microbiome’s role, with preclinical evidence suggesting an association between changes in gut bacteria and both neuropathy and neuropathic pain.27Neurobiology of Disease. Role of gut microbiota in neuropathy and neuropathic pain states: A systematic preclinical review
None of these are available as treatments yet, and the leap from animal models to effective human therapies is notoriously unreliable. But they represent a genuine shift in how researchers think about neuropathy: not just as irreversible degeneration to be managed, but as a process with identifiable molecular targets that might, in some cases, be halted or turned around if caught early enough. The emphasis on early detection tools like corneal microscopy and blood biomarkers is driven partly by this therapeutic ambition. If you can identify nerve damage before symptoms appear, you have a window where intervention might actually preserve nerve function rather than simply slow the decline.